NSF's TechAccess program and a Labor Department MOU could channel up to $224M into state AI hubs that pair training with apprenticeships and help small businesses adopt AI. The first letters of intent are due in mid‑June.

PayPal’s branded‑checkout growth has stalled. The board installed Enrique Lores and the company plans a roughly $400M push to rebuild checkout momentum.

MSU is unifying its MD and DO schools and anchoring new research and clinical investments in Detroit and Grand Rapids. The plan centralizes leadership while preserving degree pathways.

AB657 carves out a state sales-tax exemption for fusion project equipment as Wisconsin leans on UW–Madison research and a new WEDC grant to attract startups and suppliers. Backers say the move fast-tracks pilots and supply-chain opportunities.

Spanish CDMO Rovi bought a Bristol Myers Squibb injectable plant in Phoenix and signed a five-year manufacturing pact that preserves local production.

Texas Biomed will test mAb 77 in juvenile rhesus monkeys next month — a possible first antiviral for measles as cases rise. The study builds on a 2024 Science discovery.

MSU researchers published a Cell paper describing GPS, an AI platform that produced preclinical compound leads for liver cancer and pulmonary fibrosis and released the code and portal.

FisherBroyles and FBFK Law have opened San Diego‑area offices, bringing new IP and trusts teams to the region as life‑sciences and tech work fuels demand. The moves signal more choice for local companies and wealthy families.

Amazon is reportedly in talks to buy Covington’s Globalstar for about $9 billion, a move that would accelerate its low‑Earth‑orbit plans and is complicated by Apple’s 20% stake.

An Oakwood Village woman says a Cleveland Clinic gene‑editing trial has cut years of sickle‑cell pain and hospital visits. Early results from the RUBY study show promising improvements for participants.

A Lumina–Gallup study finds 47% of students have seriously considered changing majors because of AI, while 57% use AI weekly and many campus policies remain unclear.

UC San Diego researchers say the protein TYK2 helps keep early breast tumors from invading. Lab tests found TYK2‑blocking drugs increased tumor spread in mice, prompting clinical caution.

Stockton native José Hernández used the Artemis II launch to urge local students toward STEM and spotlight the outreach programs he runs back home. His foundation and school partnerships deliver hands‑on science to Central Valley youth.